MD vs LFST

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

MD

61.8
AI Score
VS
MD Wins

LFST

36.2
AI Score

Investment Advisor Scores

MD

62score
Recommendation
BUY

LFST

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric MD LFST Winner
Forward P/E 9.2937 52.6316 MD
PEG Ratio 0.2433 0 Tie
Revenue Growth 4.0% 26.1% LFST
Earnings Growth 6.5% 1927.5% LFST
Tradestie Score 61.8/100 36.2/100 MD
Profit Margin 9.0% 3.2% MD
Beta 1.00 1.00 Tie
AI Recommendation BUY AVOID NEW MONEY MD

Relative Price Performance (Last 90 Days)

MD 1M: -3.4% · 3M: -5.3% LFST 1M: -9.1% · 3M: +6.6%

Current Technical Phase

MD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.3 · Price: $25.95

LFST

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 39.4 · Price: $11.72

Fundamentals Snapshot

Metric MD LFST
Market Cap — —
Forward P/E 10.6 22.4
Trailing P/E 12.5 92.5
Revenue (TTM) — —
Revenue Growth 0.0% 0.3%
Gross Margin 0.3% 0.3%
Operating Margin 0.1% 0.1%
EPS 2.06 0.13
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.